Fundraising Fox
/Companies
Sign in

Ferryx

Bristol, GB · Founded 2019 · 6 employees on LinkedIn · 1 known investors

Find your way into Ferryx

Sign up to see every warm intro you have to Ferryx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Ferryx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Ferryx develops next-generation probiotics aimed at improving gut health for people experiencing active flare-ups of gut conditions. A 2019 spin-out from the University of Bristol, the company works to bring these probiotics into commercial production.

BiotechDeep TechHealthtech

Founders & leadership

Ferryx was founded in 2019 by Jenny Bailey Cooper.

JBJenny Bailey Cooper
Jenny Bailey CooperFounderA scientist with over 20 years of research experience in gut health and intestinal inflammation, holding a PhD in gastrointestinal immunology from the University of Bristol. In 2019 she co-founded Ferryx, a University of Bristol spin-out, where she serves as CEO and has led the development of Ferrocalm, a probiotic built around the bacterial strain Streptococcus thermophilus FX856, through funding, clinical trials, regulatory strategy, and its 2022 launch.

Investors · 1

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Companies House · registry record

View on Companies House ↗
Registered name
FERRYX LIMITED
Company number
12193693
Status
Active
Company type
Private limited company
Incorporated
6 Sept 2019
Registered office
Future Space Uwe North Gate, Filton Road, Stoke Gifford, Bristol, BS34 8RB
Nature of business (SIC)
72110 — Research and experimental development on biotechnology
Accounts
last made up to 30 Sept 2025 · next due 30 Jun 2027
Confirmation statement
last made up to 18 Dec 2025 · next due 1 Jan 2027

Current officers · 4

  • Jennifer Ruth Bailey — director, appointed 18 Nov 2019
  • Tristan Alexander Cogan — director, appointed 18 Nov 2019
  • Le Roy Dowey — director, appointed 18 May 2022
  • John Stephen Fox — director, appointed 18 Nov 2019

Source: Companies House public register · retrieved 6 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Frequently asked questions

What does Ferryx do?
Ferryx develops next-generation probiotics aimed at improving gut health for people experiencing active flare-ups of gut conditions. A 2019 spin-out from the University of Bristol, the company works to bring these probiotics into commercial production.
Who founded Ferryx?
Ferryx was founded by Jenny Bailey Cooper in 2019.
Who are Ferryx's investors?
Ferryx's investors include Deepbridge Capital.
Where is Ferryx headquartered?
Ferryx is headquartered in Bristol, GB.